EcoDrugPlus

Protein Kinase C Eta

Ensembl ID : ENSPTIG00000006620
Gene Symbol: PRKCH
2 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSPTIG00000007420
Gene Symbol: PRKCG
2 Cross references
198 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSPTIG00000019351
Gene Symbol: PRKCI
2 Cross references
195 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSPTIG00000011129
Gene Symbol: PRKD1
2 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSPTIG00000008480
Gene Symbol: PRKD3
2 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSPTIG00000021292
Gene Symbol: PRKACA
2 Cross references
283 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSPTIG00000020230
Gene Symbol: PRKACB
2 Cross references
297 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSPTIG00000007716
Gene Symbol: PRKDC
2 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSPTIG00000007016
Gene Symbol: PPP3CA
2 Cross references
230 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSPTIG00000009077
Gene Symbol: PTK2B
2 Cross references
269 Possible Orthologues:

Protein Tyrosine Kinase 6

Ensembl ID : ENSPTIG00000018694
Gene Symbol: PTK6
2 Cross references
170 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSPTIG00000009120
Gene Symbol: PTPN11
2 Cross references
251 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).